-
1
-
-
0029671047
-
Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme
-
Hargreaves RM, Slack MPE, Howard AJ, Anderson E, Ramsay ME. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996;312:160-1.
-
(1996)
BMJ
, vol.312
, pp. 160-161
-
-
Hargreaves, R.M.1
Slack, M.P.E.2
Howard, A.J.3
Anderson, E.4
Ramsay, M.E.5
-
2
-
-
0025996477
-
Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants
-
Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991;10:758-63.
-
(1991)
Pediatr Infect Dis J
, vol.10
, pp. 758-763
-
-
Watemberg, N.1
Dagan, R.2
Arbelli, Y.3
-
3
-
-
0027204111
-
Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphrheria-tetanus-pertussis vaccine at two, four and six months of age
-
Avendano A, Ferreccio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphrheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993;12:638-43.
-
(1993)
Pediatr Infect Dis J
, vol.12
, pp. 638-643
-
-
Avendano, A.1
Ferreccio, C.2
Lagos, R.3
-
4
-
-
0027955668
-
Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants
-
Kaplan SL, Lauer BA, Ward MA, et al. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994;124:323-7.
-
(1994)
J Pediatr
, vol.124
, pp. 323-327
-
-
Kaplan, S.L.1
Lauer, B.A.2
Ward, M.A.3
-
5
-
-
0028917162
-
Safety and immunogenicity of PRP-T combined with DTP: Excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period
-
Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995;95:522-7.
-
(1995)
Pediatrics
, vol.95
, pp. 522-527
-
-
Miller, M.A.1
Meschievitz, C.K.2
Ballanco, G.A.3
Daum, R.S.4
-
6
-
-
0025937312
-
The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids pertussis vaccine at two, four and six months of age
-
Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991;10:764-71.
-
(1991)
Pediatr Infect Dis J
, vol.10
, pp. 764-771
-
-
Ferreccio, C.1
Clemens, J.2
Avendano, A.3
-
7
-
-
0028197455
-
Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine
-
Dagan R, Botujansky C, Watemberg N, et al. Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J 1994;13:356-62.
-
(1994)
Pediatr Infect Dis J
, vol.13
, pp. 356-362
-
-
Dagan, R.1
Botujansky, C.2
Watemberg, N.3
-
8
-
-
0026565807
-
Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine
-
Clemens JD, Ferreccio C, Levine MM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992; 267:673-8.
-
(1992)
JAMA
, vol.267
, pp. 673-678
-
-
Clemens, J.D.1
Ferreccio, C.2
Levine, M.M.3
-
9
-
-
0028266060
-
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age
-
Gold R, Scheifele D, Barreto L, et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994;13:348-55.
-
(1994)
Pediatr Infect Dis J
, vol.13
, pp. 348-355
-
-
Gold, R.1
Scheifele, D.2
Barreto, L.3
-
10
-
-
0027369929
-
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid pertussis vaccine-tetanus toxoid?
-
Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid pertussis vaccine-tetanus toxoid? Can Med Assoc J 1995;149: 1105-12.
-
(1995)
Can Med Assoc J
, vol.149
, pp. 1105-1112
-
-
Scheifele, D.1
Barreto, L.2
Meekison, W.3
Guasparini, R.4
Friesen, B.5
-
11
-
-
0026512243
-
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age
-
Booy R, Aitken SJ, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 1992;339:507-10.
-
(1992)
Lancet
, vol.339
, pp. 507-510
-
-
Booy, R.1
Aitken, S.J.2
Taylor, S.3
-
12
-
-
0027181326
-
Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine
-
Ramsay ME, Rao M, Begg NT, Redhead K, Attwell AM. Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine. Lancet 1993;342:203-5.
-
(1993)
Lancet
, vol.342
, pp. 203-205
-
-
Ramsay, M.E.1
Rao, M.2
Begg, N.T.3
Redhead, K.4
Attwell, A.M.5
-
13
-
-
0015810637
-
Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies
-
Robbins JB, Parke JC, Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
-
(1973)
Pediatr Res
, vol.7
, pp. 103-110
-
-
Robbins, J.B.1
Parke, J.C.2
Schneerson, R.3
Whisnant, J.K.4
-
14
-
-
0008834204
-
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
-
Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
-
(1983)
J Infect Dis
, vol.147
, pp. 1100
-
-
Kayhty, H.1
Peltola, H.2
Karanko, V.3
Makela, P.H.4
-
15
-
-
0021254144
-
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine
-
Peltola H, Kayhty H, Virtanen M, Makela PH. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med 1984;310:1561-6.
-
(1984)
N Engl J Med
, vol.310
, pp. 1561-1566
-
-
Peltola, H.1
Kayhty, H.2
Virtanen, M.3
Makela, P.H.4
-
16
-
-
0021448815
-
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b
-
Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
-
(1984)
J Infect Dis
, vol.149
, pp. 1034-1035
-
-
Anderson, P.1
-
17
-
-
0001422530
-
Circulating antitoxin at the onset of diphtheria in 425 patients
-
Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients. J Immunol 1946;54:325-47.
-
(1946)
J Immunol
, vol.54
, pp. 325-347
-
-
Ipsen, J.1
-
18
-
-
0001188911
-
The prophylactic dose of homologous tetanus antitoxin
-
McComb JA. The prophylactic dose of homologous tetanus antitoxin. N Engl J Med 1964;270:175-8.
-
(1964)
N Engl J Med
, vol.270
, pp. 175-178
-
-
McComb, J.A.1
-
19
-
-
0014513924
-
Diphtheria and tetanus toxoids
-
Smith JW. Diphtheria and tetanus toxoids. Br Med Bull 1969;25:177-82.
-
(1969)
Br Med Bull
, vol.25
, pp. 177-182
-
-
Smith, J.W.1
-
20
-
-
0026596451
-
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule
-
Booy R, Taylor SA, Dobson SR, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475-8.
-
(1992)
Arch Dis Child
, vol.67
, pp. 475-478
-
-
Booy, R.1
Taylor, S.A.2
Dobson, S.R.3
-
21
-
-
0028902759
-
Adverse events and antibody response to accelerated immunisation in term and preterm infants
-
Ramsay ME, Miller E, Ashworth LA, Coleman TJ, Rush M, Waight PA. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Arch Dis Child 1995;72:230-2.
-
(1995)
Arch Dis Child
, vol.72
, pp. 230-232
-
-
Ramsay, M.E.1
Miller, E.2
Ashworth, L.A.3
Coleman, T.J.4
Rush, M.5
Waight, P.A.6
-
22
-
-
0028879984
-
Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection
-
Begg NT, Miller E, Fairley CK, et al. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine 1995;13:1547-50.
-
(1995)
Vaccine
, vol.13
, pp. 1547-1550
-
-
Begg, N.T.1
Miller, E.2
Fairley, C.K.3
-
23
-
-
0023818268
-
Trial of a new acellular pertussis vaccine in healthy adult volunteers
-
Rutter DA, Ashworth LA, Day A, Funnell S, Lovell F, Robinson A. Trial of a new acellular pertussis vaccine in healthy adult volunteers. Vaccine 1988;6:29-32.
-
(1988)
Vaccine
, vol.6
, pp. 29-32
-
-
Rutter, D.A.1
Ashworth, L.A.2
Day, A.3
Funnell, S.4
Lovell, F.5
Robinson, A.6
-
25
-
-
84948725401
-
FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children
-
Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children. JAMA 1993; 269:2359.
-
(1993)
JAMA
, vol.269
, pp. 2359
-
-
-
26
-
-
0010619389
-
Combined Hib/DTP vaccines
-
Department of Health. Combined Hib/DTP vaccines. CMO's Update 1996;10:1.
-
(1996)
CMO's Update
, vol.10
, pp. 1
-
-
-
27
-
-
0026645375
-
Symptoms after accelerated immunisation
-
Ramsay ME, Rao M, Begg NT. Symptoms after accelerated immunisation. BMJ 1992;304:1534-6.
-
(1992)
BMJ
, vol.304
, pp. 1534-1536
-
-
Ramsay, M.E.1
Rao, M.2
Begg, N.T.3
-
28
-
-
0024357076
-
Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain
-
Baraff LJ, Manclark CR, Cherry JD, Christenson P, Marcy SM. Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J 1989;8:502-7.
-
(1989)
Pediatr Infect Dis J
, vol.8
, pp. 502-507
-
-
Baraff, L.J.1
Manclark, C.R.2
Cherry, J.D.3
Christenson, P.4
Marcy, S.M.5
-
29
-
-
0026775396
-
Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine
-
Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J Pediatr 1992;121:355-62.
-
(1992)
J Pediatr
, vol.121
, pp. 355-362
-
-
Fritzell, B.1
Plotkin, S.2
-
30
-
-
0026052745
-
Differences in antibody response to whole-cell pertussis vaccines
-
Edwards KM, Decker MD, Halsey NA, et al. Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 1991;88:1019-23.
-
(1991)
Pediatrics
, vol.88
, pp. 1019-1023
-
-
Edwards, K.M.1
Decker, M.D.2
Halsey, N.A.3
-
31
-
-
0026760236
-
Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines
-
Baker JD, Halperin SA, Edwards K, Miller B, Decker M, Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr 1992;121:523-7.
-
(1992)
J Pediatr
, vol.121
, pp. 523-527
-
-
Baker, J.D.1
Halperin, S.A.2
Edwards, K.3
Miller, B.4
Decker, M.5
Stephens, D.6
-
32
-
-
0028156017
-
Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine
-
Barington T, Gyhrs A, Kristensen K, Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994;62: 9-14.
-
(1994)
Infect Immun
, vol.62
, pp. 9-14
-
-
Barington, T.1
Gyhrs, A.2
Kristensen, K.3
Heilmann, C.4
|